Under the deal, Sun Pharma is expected to produce novel Dengue drug for 17 countries
Shares of Sun Pharmaceutical Industries, India’s largest drug maker, are currently trading 0.49% lower at Rs. 794.40 on BSE. The company has singed a global deal with ICGEB for treatment of Dengue.
Under the deal, Sun Pharma is expected to produce novel Dengue drug for 17 countries.
The scrip opened at Rs. 799 and has touched a high and low of Rs. 799 and Rs. 787.1 respectively. So far 714266(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 192143.2 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1010.1 on 25-May-2015 and a 52 week low of Rs. 706.4 on 24-Nov-2015. Last one week high and low of the scrip stood at Rs. 820 and Rs. 780.55 respectively.
The promoters holding in the company stood at 54.97 % while Institutions and Non-Institutions held 35.37 % and 9.65 % respectively.
The stock is currently trading below its 200 DMA.
Under the deal, Sun Pharma is expected to produce novel Dengue drug for 17 countries.
The scrip opened at Rs. 799 and has touched a high and low of Rs. 799 and Rs. 787.1 respectively. So far 714266(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 192143.2 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1010.1 on 25-May-2015 and a 52 week low of Rs. 706.4 on 24-Nov-2015. Last one week high and low of the scrip stood at Rs. 820 and Rs. 780.55 respectively.
The promoters holding in the company stood at 54.97 % while Institutions and Non-Institutions held 35.37 % and 9.65 % respectively.
The stock is currently trading below its 200 DMA.
No comments:
Post a Comment